Paclitaxel

Back to search

Molecule Structure

Scientific Name

Paclitaxel

Description of the Drug

Paclitaxel is a taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01229

Brand Name(s)

Abraxane, Pacitaxel, Paclitaxel, Paxene, Taxol, Taxol 100

Company Owner(s)

Abraxis Bioscience Llc, Fresenius Kabi Usa Llc, Msn Laboratories Private Ltd, Mylan Laboratories Ltd, Sandoz Inc, Hospira Inc, Hq Specialty Pharma Corp, Actavis Totowa Llc, Gland Pharma Ltd, Pliva Lachema As

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tubulin PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095182

Unichem Links

SureChEMBL SCHEMBL3976
PharmGKB PA450761
Human Metabolome Database HMDB0015360
DrugBank DB01229
PubChem: Thomson Pharma 14767269 14840887
PubChem 36314
NMRShiftDB 60021370
LINCS LSM-6346
Nikkaji J17.834I
PDBe TA1
BindingDB 50001839
EPA CompTox Dashboard DTXSID9023413
DrugCentral 2044
Metabolights MTBLC45863
Brenda 8756 16457 230123 3120 230124 69683
Rhea 45863
ChemicalBook CB3273425
Guide to Pharmacology 2770
rxnorm PACLITAXEL ABRAXANE PACLITAXEL PROTEIN-BOUND
PubChem: Drugs of the Future 12013494
ChEBI 45863
ZINC ZINC000096006020